China Oncology ›› 2015, Vol. 25 ›› Issue (2): 81-86.doi: 10.3969/j.issn.1007-3969.2015.02.001

Previous Articles     Next Articles

The influence of E-cadherin/β-catenin on the glycolysis effect in PANC-1 cells

QIN Yi, LIANG Dingkong, SHI Si, JI Shunrong, ZHANG Bo, XU Wenyan, LIU Jiang, XU Jin, NI Quanxing, YU Xianjun   

  1. Department of Pancreas and Hepatobiliary Surgery, Pancreas Cancer Institute, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
  • Online:2015-02-28 Published:2015-05-13
  • Contact: YU Xianjun E-mail: yuxianjun@fudanpci.org

Abstract:
Background and purpose: Lower expression of E-cadherin is associated with metastasis of cancer cells, however, the correlation between E-cadherin and glucose metabolism has seldom been reported. This article studied the correlation between E-cadherin and glycolysis effect in PANC-1 cells. Methods: Through treatment of transforming growth factor β (TGF-β) in PANC-1 cells to decrease E-cadherin expression, knock-down the gene of E-cadherin interaction protein β-catenin, and overexpressing of E-cadherin, the effects of E-cadherin on the glucose uptake and lactate production ability and on the expression of key glycolytic genes were assessed. Results: E-cadherin negatively regulated the glycolytic effect of PANC-1 cells by inhibiting glucose uptake and lactate production (P<0.05). Moreover, E-cadherin interacting partner β-catenin significantly promoted glucose metabolism transformation in PANC- 1 cells (P<0.05). Moreover, key glycolysis regulator sirtuin 3 (SIRT3) could lower E-cadherin expression. Conclusion: Lower expression of E-cadherin induced the transformation of glucose metabolism transformation in PANC-1 cells and manipulation of E-cadherin expression level could change the glycolysis effect. Moreover, through maneuver glycolysis process could inhibit high metastatic potential of pancreatic cancer cells.

Key words: E-cadherin, β-catenin, Sirtuin3, Glycolysis